Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma

Hematol Oncol. 2019 Aug;37(3):310-313. doi: 10.1002/hon.2604. Epub 2019 May 30.

Authors

Giancarlo Fatobene, Camila da Cruz Gouveia Linardi, Frederico Moreira¹, Gabriela Matos Falcão Targueta, Fernanda Maria Santos, Rodrigo Dolphini Velasques, Vanderson Rocha, Valeria Buccheri

Affiliation

¹ Discipline of Hematology, Transfusion and Cell Therapy, Hospital das Clinicas, Faculty of Medicine, University of São Paulo, São Paulo, Brazil.

PMID: 30847943
DOI: 10.1002/hon.2604

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Autografts
Disease-Free Survival
Female
Follow-Up Studies
Hematopoietic Stem Cell Transplantation*
Hodgkin Disease / mortality*
Hodgkin Disease / therapy*
Humans
Male
Middle Aged
Retrospective Studies
Risk Factors
Survival Rate
Time Factors